BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3034797)

  • 21. Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment.
    Fankhauser CD; Gerke TA; Roth L; Sander S; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Beyer J; Hermanns T
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):781-785. PubMed ID: 30637464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review.
    Droz JP; van Oosterom AT
    Eur J Cancer; 1993; 29A(7):1038-44. PubMed ID: 8388697
    [No Abstract]   [Full Text] [Related]  

  • 23. Multivariate analysis of prognostic variables in patients with disseminated non-seminomatous testicular cancer: results from an EORTC multi-institutional phase III study.
    Stoter G; Sylvester R; Sleijfer DT; Ten Bokkel Huinink WW; Kaye SB; Jones WG; Van Oosterom AT; Vendrik CP; Spaander P; De Pauw M
    Int J Androl; 1987 Feb; 10(1):239-46. PubMed ID: 3034793
    [No Abstract]   [Full Text] [Related]  

  • 24. Surveillance programs: criteria for patient selection.
    Richie JP
    Cancer Invest; 1993; 11(1):91. PubMed ID: 8380749
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage].
    Krengli M; Pastore G; Invernizzi A; Maffei S
    Minerva Med; 1987 Feb; 78(4):209-13. PubMed ID: 3031548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic assessment in nonseminomatous testicular cancer: implications for therapy.
    Hesketh PJ; Krane RJ
    J Urol; 1990 Jul; 144(1):1-9. PubMed ID: 2162974
    [No Abstract]   [Full Text] [Related]  

  • 27. The case for relevant staging of germ cell tumors.
    Logothetis CJ
    Cancer; 1990 Feb; 65(3 Suppl):709-17. PubMed ID: 2154316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late relapse of testicular germ cell tumors.
    Carver BS; Motzer RJ; Kondagunta GV; Sogani PG; Sheinfeld J
    Urol Oncol; 2005; 23(6):441-5. PubMed ID: 16301125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy.
    Ko JJ; Bernard B; Tran B; Li H; Asif T; Stukalin I; Lee M; Day D; Alimohamed N; Sweeney CJ; Bedard PL; Heng DY
    J Clin Oncol; 2016 Mar; 34(7):714-20. PubMed ID: 26786931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D; Champion AE; Fox M
    Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center.
    Necchi A; Farè E; Vullo SL; Giannatempo P; Raggi D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Verzoni E; Grassi P; Procopio G; Pizzocaro G; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2015 Aug; 13(4):385-391.e1. PubMed ID: 25726505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Metastasis of germ cell tumors of the testis].
    Machover D; Goldschmidt E
    Ann Urol (Paris); 1991; 25(6-7):304-12. PubMed ID: 1665326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Testicular tumors--a curable disease?].
    Brunner KW; Sonntag RW; Joss R
    Schweiz Rundsch Med Prax; 1988 May; 77(20):560-4. PubMed ID: 2838878
    [No Abstract]   [Full Text] [Related]  

  • 37. Germ cell tumors.
    Bajorin DF; Motzer RJ; Bosl GJ
    Curr Ther Endocrinol Metab; 1997; 6():387-92. PubMed ID: 9174777
    [No Abstract]   [Full Text] [Related]  

  • 38. Surveillance in patients with stage I testicular nonseminomatous germ cell tumors.
    Gez E; Wygoda M; Nussbaum N; Figer A; Gil RI; Inbal M
    Cancer Invest; 1993; 11(1):10-4. PubMed ID: 8380748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of urological malignancy: the testes.
    Wilkins M; Horwich A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis, diagnosis and therapy of testicular tumors].
    Weissbach I; Bussar-Maatz R
    Urologe A; 1996 Mar; 35(2):163-72. PubMed ID: 8650851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.